UK woman killed by rare IVF risk, Ovarian Hyperstimulation Syndrome
By BBC News,
BBC News
| 04. 13. 2005
Temilola Akinbolagbe, 33, from Plumstead, south London, collapsed at a bus stop after developing Ovarian Hyperstimulation Syndrome (OHSS).
The potentially fatal form of the condition affects about one per cent of women undergoing IVF, although a less severe form is more common.
Experts believe this was the first such death from OHSS in the UK.
Mild and moderate forms of OHSS have been reported to affect up to 20% of women undergoing ovarian induction, which mimics the production of normal hormones.
It is believed there have been three other deaths from the condition in the last 30 years.
Mrs Akinbolagbe, from Plumstead, south London, started to feel ill after receiving fertility treatment.
She was taken to hospital immediately, but suffered a massive heart attack.
Mrs Akinbolagbe's life support machine was turned off five days later.
Her husband, Samuel Ifaturoti, said his wife had been "very positive" about the fertility treatment.
'Not a particular risk'
Gynaecologist John Parsons said staff at Kings College Hospital, where she had received her fertility treatment, were all shocked by Mrs Akinbolagbe's death.
He said: "We...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Paula Siverino Bavio, BioNews | 03.16.2026
State flag of Peru via Wikimedia Commons licensed under CC by SA 2.0
A recent surrogacy case in Peru had a good outcome for one family, but does not provide wider certainty for families, surrogates or clinicians, writes Dr Paula...